Judah Frommer
Stock Analyst at Morgan Stanley
(3.60)
# 1,327
Out of 4,479 analysts
129
Total ratings
54.37%
Success rate
2.86%
Average return
Main Sectors:
33 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GLPG Galapagos NV | Maintains: Equal-Weight | $38 | $25.34 | +49.96% | 2 | Apr 22, 2024 | |
| MURA Mural Oncology | Initiates: Overweight | $13 | $3.05 | +326.23% | 1 | Apr 4, 2024 | |
| PROK ProKidney | Assumes: Equal-Weight | $3 | $2.24 | +33.93% | 1 | Mar 7, 2024 | |
| ACLX Arcellx | Initiates: Overweight | $81 | $53.25 | +52.11% | 1 | Mar 7, 2024 | |
| JSPR Jasper Therapeutics | Reiterates: Outperform | $40 | $22.78 | +75.59% | 8 | Aug 14, 2023 | |
| AKLI Akili | Reiterates: Outperform | $4 | $0.43 | +825.93% | 3 | Aug 11, 2023 | |
| ABOS Acumen Pharmaceuticals | Reiterates: Outperform | $13 | $2.27 | +472.69% | 5 | Aug 9, 2023 | |
| RNA Avidity Biosciences | Reiterates: Outperform | $30 | $38.80 | -22.68% | 8 | Aug 9, 2023 | |
| STOK Stoke Therapeutics | Reiterates: Outperform | $23 | $12.83 | +79.27% | 5 | Aug 8, 2023 | |
| PTCT PTC Therapeutics | Reiterates: Neutral | $50 | $30.39 | +64.53% | 8 | Jul 20, 2023 | |
| SRPT Sarepta Therapeutics | Reiterates: Neutral | $141 | $154.20 | -8.56% | 13 | Jun 23, 2023 | |
| IKNA Ikena Oncology | Reiterates: Outperform | $13 | $1.63 | +697.55% | 5 | May 16, 2023 | |
| ATAI Atai Life Sciences | Reiterates: Outperform | $9 | $1.30 | +592.31% | 5 | May 12, 2023 | |
| EFTR eFFECTOR Therapeutics | Maintains: Outperform | $175 → $138 | $0.18 | +76,288.89% | 6 | May 10, 2023 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Outperform | $21 → $22 | $20.30 | +8.37% | 2 | Apr 3, 2023 | |
| CADL Candel Therapeutics | Maintains: Outperform | $8 → $7 | $6.25 | +12.00% | 3 | Mar 31, 2023 | |
| FULC Fulcrum Therapeutics | Downgrades: Neutral | $11 → $8 | $6.10 | +31.15% | 5 | Mar 10, 2023 | |
| INBX Inhibrx | Reiterates: Outperform | $46 | $13.56 | +239.23% | 4 | Mar 7, 2023 | |
| ESPR Esperion Therapeutics | Upgrades: Neutral | $6.5 → $7 | $2.34 | +199.15% | 6 | Mar 7, 2023 | |
| QURE uniQure | Maintains: Outperform | $51 → $55 | $4.01 | +1,271.57% | 3 | Feb 28, 2023 | |
| INSM Insmed | Reiterates: Outperform | $46 | $64.50 | -28.68% | 1 | Feb 24, 2023 | |
| ACI Albertsons Companies | Initiates: Outperform | n/a | $19.86 | - | 1 | Jul 21, 2020 | |
| FIVE Five Below | Maintains: Outperform | n/a | $106.15 | - | 6 | Jun 10, 2020 | |
| OLLI Ollie's Bargain Outlet Holdings | Downgrades: Neutral | n/a | $98.32 | - | 4 | May 26, 2020 | |
| USFD US Foods Holding | Maintains: Outperform | n/a | $52.87 | - | 3 | May 6, 2020 | |
| SYY Sysco | Maintains: Outperform | n/a | $70.59 | - | 3 | May 6, 2020 | |
| SFM Sprouts Farmers Market | Maintains: Neutral | n/a | $82.97 | - | 1 | May 6, 2020 | |
| KR The Kroger Co. | Maintains: Neutral | n/a | $50.43 | - | 6 | Apr 29, 2020 | |
| PFGC Performance Food Group | Reinstates: Outperform | n/a | $64.56 | - | 2 | Apr 20, 2020 | |
| DLTR Dollar Tree | Maintains: Outperform | n/a | $107.11 | - | 5 | Mar 5, 2020 | |
| BJ BJ's Wholesale Club Holdings | Initiates: Outperform | n/a | $85.63 | - | 1 | Feb 13, 2020 | |
| COST Costco | Initiates: Neutral | n/a | $859.36 | - | 1 | Feb 13, 2020 | |
| DG Dollar General | Maintains: Neutral | n/a | $129.47 | - | 1 | Jun 1, 2018 |
Galapagos NV
Apr 22, 2024
Maintains: Equal-Weight
Price Target: $38
Current: $25.34
Upside: +49.96%
Mural Oncology
Apr 4, 2024
Initiates: Overweight
Price Target: $13
Current: $3.05
Upside: +326.23%
ProKidney
Mar 7, 2024
Assumes: Equal-Weight
Price Target: $3
Current: $2.24
Upside: +33.93%
Arcellx
Mar 7, 2024
Initiates: Overweight
Price Target: $81
Current: $53.25
Upside: +52.11%
Jasper Therapeutics
Aug 14, 2023
Reiterates: Outperform
Price Target: $40
Current: $22.78
Upside: +75.59%
Akili
Aug 11, 2023
Reiterates: Outperform
Price Target: $4
Current: $0.43
Upside: +825.93%
Acumen Pharmaceuticals
Aug 9, 2023
Reiterates: Outperform
Price Target: $13
Current: $2.27
Upside: +472.69%
Avidity Biosciences
Aug 9, 2023
Reiterates: Outperform
Price Target: $30
Current: $38.80
Upside: -22.68%
Stoke Therapeutics
Aug 8, 2023
Reiterates: Outperform
Price Target: $23
Current: $12.83
Upside: +79.27%
PTC Therapeutics
Jul 20, 2023
Reiterates: Neutral
Price Target: $50
Current: $30.39
Upside: +64.53%
Sarepta Therapeutics
Jun 23, 2023
Reiterates: Neutral
Price Target: $141
Current: $154.20
Upside: -8.56%
Ikena Oncology
May 16, 2023
Reiterates: Outperform
Price Target: $13
Current: $1.63
Upside: +697.55%
Atai Life Sciences
May 12, 2023
Reiterates: Outperform
Price Target: $9
Current: $1.30
Upside: +592.31%
eFFECTOR Therapeutics
May 10, 2023
Maintains: Outperform
Price Target: $175 → $138
Current: $0.18
Upside: +76,288.89%
NewAmsterdam Pharma Company
Apr 3, 2023
Maintains: Outperform
Price Target: $21 → $22
Current: $20.30
Upside: +8.37%
Candel Therapeutics
Mar 31, 2023
Maintains: Outperform
Price Target: $8 → $7
Current: $6.25
Upside: +12.00%
Fulcrum Therapeutics
Mar 10, 2023
Downgrades: Neutral
Price Target: $11 → $8
Current: $6.10
Upside: +31.15%
Inhibrx
Mar 7, 2023
Reiterates: Outperform
Price Target: $46
Current: $13.56
Upside: +239.23%
Esperion Therapeutics
Mar 7, 2023
Upgrades: Neutral
Price Target: $6.5 → $7
Current: $2.34
Upside: +199.15%
uniQure
Feb 28, 2023
Maintains: Outperform
Price Target: $51 → $55
Current: $4.01
Upside: +1,271.57%
Insmed
Feb 24, 2023
Reiterates: Outperform
Price Target: $46
Current: $64.50
Upside: -28.68%
Albertsons Companies
Jul 21, 2020
Initiates: Outperform
Price Target: n/a
Current: $19.86
Upside: -
Five Below
Jun 10, 2020
Maintains: Outperform
Price Target: n/a
Current: $106.15
Upside: -
Ollie's Bargain Outlet Holdings
May 26, 2020
Downgrades: Neutral
Price Target: n/a
Current: $98.32
Upside: -
US Foods Holding
May 6, 2020
Maintains: Outperform
Price Target: n/a
Current: $52.87
Upside: -
Sysco
May 6, 2020
Maintains: Outperform
Price Target: n/a
Current: $70.59
Upside: -
Sprouts Farmers Market
May 6, 2020
Maintains: Neutral
Price Target: n/a
Current: $82.97
Upside: -
The Kroger Co.
Apr 29, 2020
Maintains: Neutral
Price Target: n/a
Current: $50.43
Upside: -
Performance Food Group
Apr 20, 2020
Reinstates: Outperform
Price Target: n/a
Current: $64.56
Upside: -
Dollar Tree
Mar 5, 2020
Maintains: Outperform
Price Target: n/a
Current: $107.11
Upside: -
BJ's Wholesale Club Holdings
Feb 13, 2020
Initiates: Outperform
Price Target: n/a
Current: $85.63
Upside: -
Costco
Feb 13, 2020
Initiates: Neutral
Price Target: n/a
Current: $859.36
Upside: -
Dollar General
Jun 1, 2018
Maintains: Neutral
Price Target: n/a
Current: $129.47
Upside: -